Behaviour of glibenclamide on repeated administration to diabetic patients.
Six maturity onset diabetic patients took glibenclamide 5 mg by mouth, every morning 10 min before a standard breakfast. Serum levels of immunoreactive glibenclamide, glucose and immunoreactive insulin were measured repeatedly on the first and 15th days of treatment. Measured glibenclamide blood levels were in close agreement with an analogue computer simulation of data obtained from healthy volunteers: there was no accumulation of drug in the blood, but there was strong evidence for the existence of a slowly equilibrating "deep" compartment. Considerable insulin release and correction of the breakfast-induced hyperglycaemia were observed immediately after administration of the drug, as well as 5 h later, at lunch time. The clinical significance of blood levels of glibenclamide, as well as the correlation of pharmacokinetics with pharmacodynamics, are discussed in the light of these results.
D000284:Administration, Oral; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood*; D004435:Eating; D005905:Glyburide / Q000008:administration & dosage / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000097:blood; D008954:Models, Biological; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D005905:Glyburide